Biomarkers of neuroprogression and late staging in bipolar disorder: A systematic review. (March 2023)

• Record Type: Journal Article
• Authors: Grewal, Sonya; McKinlay, Stuart; Kapczinski, Flávio; Pfaffenseller, Bianca; Wollenhaupt-Aguiar, Bianca
• Is Part Of: Australian and New Zealand journal of psychiatry. Volume 57:Number 3(2023)
• Page Start: 328
• Page End: 343
• Publication Date: 2023-03
• Subjects: Bipolar disorder -- staging -- biomarkers -- neuroprogression -- illness progression; Psychiatry -- Periodicals; Psychiatry -- Australia -- Periodicals; Psychiatry -- New Zealand -- Periodicals; 616.89005
• DOI: 10.1177/00048674221091731
• Languages: English
• ISSNs: 0004-8674

Abstract

Background: Bipolar disorder may undertake a progressive course in a subset of patients, and research efforts have been made to understand the biological basis underlying this process. This systematic review examined the literature available on biological markers associated with illness progression in bipolar disorder. Methods: Peer-reviewed articles were assessed using Embase, PsycINFO and PubMed, as well as from external sources. After initial screening, a total of 871 citations from databases and other sources were identified. Participants with a diagnosis of bipolar disorder were included in our systematic review; however, studies with participants younger than 15 or older than 65 were excluded. All studies were assessed using the Newcastle-Ottawa Scale assessment tool, and data pertaining to the results were extracted into tabular form using Google Sheets and Google Documents. The systematic review was registered on PROSPERO international prospective register of systematic reviews (ID Number: CRD42020154305). Results: A total of 35 studies were included in the systematic review. Increased ventricular size and reduction of grey matter volume were the most common brain changes associated with illness progression in bipolar disorder. Among the several biomarkers evaluated in this systematic review, findings also indicate a role of peripheral inflammatory markers in this process. Discussion: The studies evaluating the biological basis of the illness progression in bipolar disorder are still scarce and heterogeneous. However, current evidence supports the notion of neuroprogression, the pathophysiological process related to progressive brain changes associated with clinical progression in patients with bipolar disorder. The increase in peripheral inflammatory biomarkers and the neuroanatomical changes in bipolar disorder suggest progressive systemic and structural brain alterations, respectively.